Table 1:

Baseline data of patients before and after propensity score matching

Unmatched ( n = 310)
Matched ( n = 206)
ACURATE ( n = 131) SAPIEN ( n = 179) P -values ACURATE ( n = 103) SAPIEN ( n = 103) P -values
Demographics and basic clinical data
 Age (years)83 ± 580 ± 10<0.00183 ± 583 ± 50.5
 Male sex (%)41540.0344420.8
 BMI (kg/m 2 ) 27 ± 527 ± 50.9427 ± 527 ± 50.7
 GFR (ml/min/1.73 m 2 ) 62 ± 2660 ± 280.5862 ± 2762 ± 271.0
 NYHA ≥ III (%)91930.4491911.0
 STS-PROM (%)7.70 ± 4.68.05 ± 6.00.567.95 ± 4.87.94 ± 5.31.0
Imaging and invasive measurements
Pmean (mmHg) 43 ± 1641 ± 160.2544 ± 1642 ± 140.4
 EF (%)55 ± 1151 ± 140.00555 ± 1155 ± 121.0
 Interventricular septum (mm)13 ± 213 ± 30.9313 ± 213 ± 20.9
 Agatston score (AU)2849 ± 14162864 ± 14220.932777 ± 13772728 ± 12760.8
 Effective system annulus (mm)23.6 ± 2.024.3 ± 2.10.00323.7 ± 2.023.8 ± 2.00.7
Clinical history
 s. p. syncope (%)13170.3514160.5
 s. p. cardiac decompensation (%)34400.2334360.8
 IDDM (%)660.85860.6
 COPD (%)18230.2520201.0
 Atrial fibrillation (%)40320.1937390.8
 Hypertension (%)96970.6297971.0
 Hypercholesterolaemia (%)41510.0948480.9
 CAD (%)69760.2169691.0
 Myocardial infarction (%)20290.0624220.8
 MR ≥ 2+ (%)21180.6421170.5
 AR ≥ 2+ (%)15190.3916120.3
 TR ≥ 2+ (%)9130.2411111.0
 Stroke (%)17160.8916150.9
 ICA stenosis (%)12190.1015140.7
 Pacemaker (%)14170.4615150.8
 PCI (%)41390.7141430.8
 Prior CABG surgery (%)22340.0324230.9
 Prior AVR surgery (%)040.008001.0
Unmatched ( n = 310)
Matched ( n = 206)
ACURATE ( n = 131) SAPIEN ( n = 179) P -values ACURATE ( n = 103) SAPIEN ( n = 103) P -values
Demographics and basic clinical data
 Age (years)83 ± 580 ± 10<0.00183 ± 583 ± 50.5
 Male sex (%)41540.0344420.8
 BMI (kg/m 2 ) 27 ± 527 ± 50.9427 ± 527 ± 50.7
 GFR (ml/min/1.73 m 2 ) 62 ± 2660 ± 280.5862 ± 2762 ± 271.0
 NYHA ≥ III (%)91930.4491911.0
 STS-PROM (%)7.70 ± 4.68.05 ± 6.00.567.95 ± 4.87.94 ± 5.31.0
Imaging and invasive measurements
Pmean (mmHg) 43 ± 1641 ± 160.2544 ± 1642 ± 140.4
 EF (%)55 ± 1151 ± 140.00555 ± 1155 ± 121.0
 Interventricular septum (mm)13 ± 213 ± 30.9313 ± 213 ± 20.9
 Agatston score (AU)2849 ± 14162864 ± 14220.932777 ± 13772728 ± 12760.8
 Effective system annulus (mm)23.6 ± 2.024.3 ± 2.10.00323.7 ± 2.023.8 ± 2.00.7
Clinical history
 s. p. syncope (%)13170.3514160.5
 s. p. cardiac decompensation (%)34400.2334360.8
 IDDM (%)660.85860.6
 COPD (%)18230.2520201.0
 Atrial fibrillation (%)40320.1937390.8
 Hypertension (%)96970.6297971.0
 Hypercholesterolaemia (%)41510.0948480.9
 CAD (%)69760.2169691.0
 Myocardial infarction (%)20290.0624220.8
 MR ≥ 2+ (%)21180.6421170.5
 AR ≥ 2+ (%)15190.3916120.3
 TR ≥ 2+ (%)9130.2411111.0
 Stroke (%)17160.8916150.9
 ICA stenosis (%)12190.1015140.7
 Pacemaker (%)14170.4615150.8
 PCI (%)41390.7141430.8
 Prior CABG surgery (%)22340.0324230.9
 Prior AVR surgery (%)040.008001.0

CAD: coronary artery disease; ICA: internal carotid artery; s.p.: status post; AR: aortic valve regurgitation; AVR: aortic valve replacement; Pmean : mean transvalvular gradients; BMI: body mass index; CABG: coronary artery bypass crafting; COPD: chronic obstructive pulmonary disease; EF: left ventricular ejection fraction; GFR: glomerular filtration rate; HTN: arterial hypertension; IDDM: insulin-dependent diabetes mellitus; MR: mitral regurgitation; NYHA: New York Heart Association stages of heart failure; PAOD: peripheral arterial occlusive disease; PCI: percutaneous coronary intervention; STS-PROM: Society of Thoracic Surgeons risk predicted risk of mortality; TR: tricuspid regurgitation.

Table 1:

Baseline data of patients before and after propensity score matching

Unmatched ( n = 310)
Matched ( n = 206)
ACURATE ( n = 131) SAPIEN ( n = 179) P -values ACURATE ( n = 103) SAPIEN ( n = 103) P -values
Demographics and basic clinical data
 Age (years)83 ± 580 ± 10<0.00183 ± 583 ± 50.5
 Male sex (%)41540.0344420.8
 BMI (kg/m 2 ) 27 ± 527 ± 50.9427 ± 527 ± 50.7
 GFR (ml/min/1.73 m 2 ) 62 ± 2660 ± 280.5862 ± 2762 ± 271.0
 NYHA ≥ III (%)91930.4491911.0
 STS-PROM (%)7.70 ± 4.68.05 ± 6.00.567.95 ± 4.87.94 ± 5.31.0
Imaging and invasive measurements
Pmean (mmHg) 43 ± 1641 ± 160.2544 ± 1642 ± 140.4
 EF (%)55 ± 1151 ± 140.00555 ± 1155 ± 121.0
 Interventricular septum (mm)13 ± 213 ± 30.9313 ± 213 ± 20.9
 Agatston score (AU)2849 ± 14162864 ± 14220.932777 ± 13772728 ± 12760.8
 Effective system annulus (mm)23.6 ± 2.024.3 ± 2.10.00323.7 ± 2.023.8 ± 2.00.7
Clinical history
 s. p. syncope (%)13170.3514160.5
 s. p. cardiac decompensation (%)34400.2334360.8
 IDDM (%)660.85860.6
 COPD (%)18230.2520201.0
 Atrial fibrillation (%)40320.1937390.8
 Hypertension (%)96970.6297971.0
 Hypercholesterolaemia (%)41510.0948480.9
 CAD (%)69760.2169691.0
 Myocardial infarction (%)20290.0624220.8
 MR ≥ 2+ (%)21180.6421170.5
 AR ≥ 2+ (%)15190.3916120.3
 TR ≥ 2+ (%)9130.2411111.0
 Stroke (%)17160.8916150.9
 ICA stenosis (%)12190.1015140.7
 Pacemaker (%)14170.4615150.8
 PCI (%)41390.7141430.8
 Prior CABG surgery (%)22340.0324230.9
 Prior AVR surgery (%)040.008001.0
Unmatched ( n = 310)
Matched ( n = 206)
ACURATE ( n = 131) SAPIEN ( n = 179) P -values ACURATE ( n = 103) SAPIEN ( n = 103) P -values
Demographics and basic clinical data
 Age (years)83 ± 580 ± 10<0.00183 ± 583 ± 50.5
 Male sex (%)41540.0344420.8
 BMI (kg/m 2 ) 27 ± 527 ± 50.9427 ± 527 ± 50.7
 GFR (ml/min/1.73 m 2 ) 62 ± 2660 ± 280.5862 ± 2762 ± 271.0
 NYHA ≥ III (%)91930.4491911.0
 STS-PROM (%)7.70 ± 4.68.05 ± 6.00.567.95 ± 4.87.94 ± 5.31.0
Imaging and invasive measurements
Pmean (mmHg) 43 ± 1641 ± 160.2544 ± 1642 ± 140.4
 EF (%)55 ± 1151 ± 140.00555 ± 1155 ± 121.0
 Interventricular septum (mm)13 ± 213 ± 30.9313 ± 213 ± 20.9
 Agatston score (AU)2849 ± 14162864 ± 14220.932777 ± 13772728 ± 12760.8
 Effective system annulus (mm)23.6 ± 2.024.3 ± 2.10.00323.7 ± 2.023.8 ± 2.00.7
Clinical history
 s. p. syncope (%)13170.3514160.5
 s. p. cardiac decompensation (%)34400.2334360.8
 IDDM (%)660.85860.6
 COPD (%)18230.2520201.0
 Atrial fibrillation (%)40320.1937390.8
 Hypertension (%)96970.6297971.0
 Hypercholesterolaemia (%)41510.0948480.9
 CAD (%)69760.2169691.0
 Myocardial infarction (%)20290.0624220.8
 MR ≥ 2+ (%)21180.6421170.5
 AR ≥ 2+ (%)15190.3916120.3
 TR ≥ 2+ (%)9130.2411111.0
 Stroke (%)17160.8916150.9
 ICA stenosis (%)12190.1015140.7
 Pacemaker (%)14170.4615150.8
 PCI (%)41390.7141430.8
 Prior CABG surgery (%)22340.0324230.9
 Prior AVR surgery (%)040.008001.0

CAD: coronary artery disease; ICA: internal carotid artery; s.p.: status post; AR: aortic valve regurgitation; AVR: aortic valve replacement; Pmean : mean transvalvular gradients; BMI: body mass index; CABG: coronary artery bypass crafting; COPD: chronic obstructive pulmonary disease; EF: left ventricular ejection fraction; GFR: glomerular filtration rate; HTN: arterial hypertension; IDDM: insulin-dependent diabetes mellitus; MR: mitral regurgitation; NYHA: New York Heart Association stages of heart failure; PAOD: peripheral arterial occlusive disease; PCI: percutaneous coronary intervention; STS-PROM: Society of Thoracic Surgeons risk predicted risk of mortality; TR: tricuspid regurgitation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close